Latest stories on NGNE
Newleos Names Rohan Palekar as Board Chairman | NGNE Stock News
StockTitan50 · neutralgeneral
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NGNE Stock News
StockTitan50 · neutralgeneral
Neurogene: 'Hold' EMBOLDEN Study Underway And 2nd Half 2027 Topline Data
Seeking Alpha56 · neutralanalyst
Neurogene Inc. (NGNE) files 8-K
SEC 8-K50 · neutralgeneral
Neurogene prices $125M equity offering
Seeking Alpha24 · bearishgeneral
Neurogene Inc. Announces Pricing of $125 Million Public Offering | NGNE Stock News
StockTitan24 · bearishgeneral
Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome - Slideshow
Seeking Alpha50 · neutralgeneral
Neurogene launches public stock offering
Seeking Alpha24 · bearishgeneral
Neurogene Inc. Announces Proposed Public Offering | NGNE Stock News
StockTitan24 · bearishgeneral
Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome Transcript
Seeking Alpha56 · neutralproduct/pr
Neurogene reports promising long-term NGN-401 Rett data
TipRanks73 · bullishproduct/pr
Neurogene Inc. (NGNE) files 8-K
SEC 8-K50 · neutralgeneral
Neurogene Completes Dosing in Embolden Rett Trial
TipRanks59 · neutralproduct/pr
Neurogene Inc. (NGNE) files 8-K
SEC 8-K50 · neutralgeneral
Neurogene Stockholders Vote on Directors and Executive Pay
TipRanks50 · neutralgeneral
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NGNE Stock News
StockTitan50 · neutralgeneral